Electroencephalogram in Cirrhotic Children without Clinical Encephalopathy

Document Type : original article

Authors

1 Department of Pediatrics, Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Department of Pediatrics, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran.

3 Student Research Committee, Zabol University of Medical Sciences, Zabol, Iran.

4 Internal Medicine Department, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran.

5 Department of Community Medicine, Faculty of Medicine, Zabol University of Medical Sciences, Zabol, Iran.

Abstract

Background: This study aimed to determine the electroencephalogram (EEG) findings in children with hepatic cirrhosis, which occurred without clinical encephalopathy.
Methods: The present study was conducted in an observational-analytical way at Amir-al-momenin Zabol Hospital, Zabol University of Medical Sciences, Iran. In this study, 50 children with hepatic cirrhosis without encephalopathy symptoms and 50 healthy children were evaluated and studied regarding abnormal findings in EEG. Finally, the data were analyzed using SPSS V22 software.
Results: The mean and standard deviation of the age of the studied population was 57.6 ± 76.17 months. Out of a total of 50 children with hepatic cirrhosis, 21 children (42%) had abnormal findings in EEG, while none of the children in the healthy group had abnormal findings in EEG. There was a significant relationship between abnormal EEG findings and older age (P=0.001), underlying autoimmune hepatitis disease (P=0.011), and abnormal (increased) serum levels of Alanineamino Transferase (ALT) (P=0.030) and aspartate amino transferase (AST) (P=0.010) enzymes. Children with cirrhosis who had abnormal EEG findings had a higher average Pediatric End-Stage Liver Disease (PELD) score (18.1 ± 4.1) than patients with normal EEG findings (17.2 ± 3.7), but these findings were not statistically significant and noticeable (P=0.073). The sensitivity of EEG for predicting the severity of cirrhosis was estimated to be 70% and its specificity was 65%.
Conclusion: The results of the present study indicated that the higher sensitivity of EEG compared to the specificity in predicting the severity of cirrhosis indicates that EEG is more useful to rule out severe cirrhosis or to screen cirrhosis patients at risk of deterioration than to confirm its diagnosis.

Keywords

References

  1. Stroffolini T, Sagnelli E, Gaeta GB, Sagnelli C, Andriulli A, Brancaccio G, et al. Characteristics of liver cirrhosis in Italy: evidence for a decreasing role of HCV aetiology. European journal of internal medicine. 2017 Mar 1;38:68-72.
  2. Nault JC, Ningarhari M, Rebouissou S, Zucman-Rossi J. The role of telomeres and telomerase in cirrhosis and liver cancer. Nature Reviews Gastroenterology & Hepatology. 2019 Sep; 16(9):544-58.
  3. Zhai M, Long J, Liu S, Liu C, Li L, Yang L, et al. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY). 2021 Jan 15; 13(1):279.
  4. Akhan O, Akpinar E, Karcaaltincaba M, Haliloglu M, Akata D, Karaosmanoglu AD, et al. Imaging findings of liver involvement of Wilson's disease. European journal of radiology. 2009 Jan 1; 69(1):147-55.
  5. McGoogan KE, Smith PB, Choi SS, Berman W, Jhaveri R. Performance of the AST to platelet ratio index (APRI) as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. Journal of pediatric gastroenterology and nutrition. 2010 Mar; 50(3):344.
  6. Lebensztejn DM, Skiba E, Sobaniec‐Lotowska M, Kaczmarski M. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B. Hepatology. 2005 Jun; 41(6):1434-5.
  7. Kelly D. The Child with Chronic Liver Disease. Atlas of Pediatric Hepatology. 2018:71-80.
  8. Rahmani P, Farahmand F, Heidari G, Sayarifard A. Noninvasive markers for esophageal varices in children with cirrhosis. Clinical and Experimental Pediatrics. 2021 Jan; 64(1):31.
  9. Amodio P, Pellegrini A, Amista P, Luise S, Del Piccolo F, Mapelli D, et al. Neuropsychological–neurophysiological alterations and brain atrophy in cirrhotic patients. Metabolic brain disease. 2003 Mar; 18(1):63-78.
  10. Shahramian I, Mohammadi MH, Akbari A, Sargazi A, Delaramnasab M, Bazi A. Electroencephalogram Abnormalities in Very Young Children with Acute Hepatitis A Infection: A Cross-Sectional Study. Journal of Comprehensive Pediatrics. 2019 Aug 31; 10(3).
  11. Morgan MY, Amodio P, Cook NA, Jackson CD, Kircheis G, Lauridsen MM, et al. Qualifying and quantifying minimal hepatic encephalopathy. Metabolic brain disease. 2016 Dec; 31(6):1217-29.
  12. Direkze S, Jalan R. Diagnosis and treatment of low-grade hepatic encephalopathy. Digestive Diseases. 2015; 33(4):562-9.
  13. Srivastava A, Chaturvedi S, Gupta RK, Malik R, Mathias A, Jagannathan NR, et al. Minimal hepatic encephalopathy in children with chronic liver disease: prevalence, pathogenesis and magnetic resonance-based diagnosis. Journal of hepatology. 2017 Mar 1; 66(3):528-36.
  14. Mack CL, Zelko FA, Lokar J, Superina R, Alonso EM, Blei AT, et al. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability. Pediatrics. 2006 Mar 1; 117(3):e405-12.
  15. Montagnese S, Bajaj JS. Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues. Drugs. 2019 Feb 1; 79(1):11-6.
  16. Tapper EB. Predicting overt hepatic encephalopathy for the population with cirrhosis. Hepatology. 2019 Jul; 70(1):403-9.
  17. Amodio P, Del Piccolo F, Pettenò E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. Journal of hepatology. 2001 Jul 1; 35(1):37-45.
  18. Marchetti P, D'Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, et al. Electroencephalography in patients with cirrhosis. Gastroenterology. 2011 Nov 1; 141(5):1680-9.
  19. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver International. 2009 Jul; 29(6):789-96.
  20. Xu XY, Ding HG, Li WG, Jia JD, Wei L, Duan ZP, et al. Chinese guidelines on management of hepatic encephalopathy in cirrhosis. World journal of gastroenterology. 2019 Sep 28; 25(36):5403.
  21. Sahney A, Wadhawan M. Encephalopathy in cirrhosis: prevention and management. Journal of Clinical and Experimental Hepatology. 2022 May 1; 12(3):927-36.
  22. Dehghani SM, Imanieh MH, Haghighat M, Malekpour A, Falizkar Z. Etiology and complications of liver cirrhosis in children: report of a single center from southern Iran. Middle East Journal of Digestive Diseases (MEJDD). 2013; 5(1):41-6.
  23. Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Journal of Gastroenterology and Hepatology. 2016 Jun; 31(6):1203-9.
  24. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW. The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology. 1996 Sep; 24(3):556-60.
  25. Formentin C, Zarantonello L, Mangini C, Frigo AC, Montagnese S, Merkel C. Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE). Liver international. 2021 May; 41(5):1070-82.
  26. Patel NP, Chafekar ND, Sonwane PB. Slowing of Alpha Waves on EEG, an Early Marker of Minimal Hepatic Encephalopathy. MVP Journal of Medical Sciences. 2019 Jun 1:60-5.
  27. Assem ES, Ahmed F EG, Mohsen EH, Tarek MM A. Diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis.2007.
  28. Tanaka H, Ueda H, Kida Y, Hamagami H, Tsuji T, Ichinose M. Hepatic encephalopathy with status epileptics: a case report. World journal of gastroenterology: WJG. 2006 Mar 3; 12(11):1793.
  29. Ficker DM, Westmoreland BF, Sharbrough FW. Epileptiform abnormalities in hepatic encephalopathy. Journal of clinical neurophysiology. 1997 May 1; 14(3):230-4.
  30. Eleftheriadis N, Fourla E, Eleftheriadis D, Karlovasitou A. Status epilepticus as a manifestation of hepatic encephalopathy. Acta neurologica scandinavica. 2003 Feb; 107(2):142-4.
  31. Jo YM, Lee SW, Han SY, Baek YH, Ahn JH, Choi WJ, et al. Nonconvulsive status epilepticus disguising as hepatic encephalopathy. World Journal of Gastroenterology: WJG. 2015 Apr 4; 21(16):5105.
  32. Newey CR, George P, Sarwal A, So N, Hantus S. Electro-Radiological Observations of Grade III/IV Hepatic Encephalopathy Patients with Seizures. Neurocrit Care. 2018; 28:97–103.
  33. Mitra LG, Rajput G, Saluja V, Kumar G. EEG abnormality as a prognostic factor in cirrhotic patients with Grade III-IV hepatic encephalopathy requiring mechanical ventilation: A retrospective analysis. Journal of Clinical and Translational Research. 2021 Aug 8; 7(4):467.
  34. Dasgupta A, Debbarma A, Choudhury SK. Evaluation of the Role of Electroencephalography in the Early Diagnosis of Minimal Hepatic Encephalopathy in Patients with Cirrhosis of Liver. J Evid Based Med Healthc. 2019; 6:2945–9.
  35. Montagnese S, De Rui M, Schiff S, Ceranto E, Valenti P, Angeli P, et al. Prognostic benefit of the addition of a quantitative index of hepatic encephalopathy to the MELD score: the MELD‐EEG. Liver international. 2015 Jan; 35(1):58-64.
  36. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. The American journal of gastroenterology. 2003 Jun 1;98(6):1395-9.

 

Journal of Pediatric Perspectives
Volume 12, Issue 6
June 2024
Pages 18841-18850

Files

Share

How to cite

Statistics